| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. | Director | Common Stock | 2,031,730 | $44,068,223 | $21.69 | 12 Jun 2025 | Indirect |
| ADMA BIOLOGICS, INC. | Director | Common Stock | 87,330 | $1,767,559 | $20.24 | 16 Jun 2025 | Direct |
| Marker Therapeutics, Inc. | Director | Common Stock | 325,370 | $1,041,184 | $3.2 | 23 Dec 2024 | Indirect |
| ADMA BIOLOGICS, INC. | Director | Stock Option (Right to Buy) | 0 | $59,581 | $3.66 | 13 Jun 2025 | Direct |
| Marker Therapeutics, Inc. | Director | Common Stock | 2,968 | $9,498 | $3.2 | 23 Dec 2024 | Direct |
| Zosano Pharma Corp | Director | Common Stock | 2,718,226 | 10 Jun 2021 | (2) | ||
| Marker Therapeutics, Inc. | Director | Stock Option (right to buy) | 137,330 | 17 Nov 2025 | Direct | ||
| Zosano Pharma Corp | Director | Stock Option (Right to Buy) | 30,000 | 10 Jun 2021 | Direct | ||
| Zosano Pharma Corp | Director | Common Stock | 22,500 | 10 Jun 2021 | Direct | ||
| Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 0 | 23 Jul 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | 17 Nov 2025 | 2 | $0 | 4 | Director | 19 Nov 2025, 16:01 |
| ELEV | Elevation Oncology, Inc. | 23 Jul 2025 | 5 | $0 | 4 | Director | 24 Jul 2025, 16:30 |
| ADMA | ADMA BIOLOGICS, INC. | 12 Jun 2025 | 23 | -$7,688,570 | 4 | Director | 16 Jun 2025, 21:00 |
| ELEV | Elevation Oncology, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:20 |
| ADMA | ADMA BIOLOGICS, INC. | 19 Feb 2025 | 2 | $0 | 4 | Director | 21 Feb 2025, 21:05 |
| MRKR | Marker Therapeutics, Inc. | 12 Feb 2025 | 1 | $0 | 4 | Director | 14 Feb 2025, 17:20 |
| MRKR | Marker Therapeutics, Inc. | 23 Dec 2024 | 1 | $35,472 | 4 | Director | 26 Dec 2024, 16:01 |
| ADMA | ADMA BIOLOGICS, INC. | 27 Nov 2024 | 2 | $97,200 | 4 | Director | 02 Dec 2024, 21:02 |
| ELEV | Elevation Oncology, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:26 |
| ADMA | ADMA BIOLOGICS, INC. | 18 Mar 2024 | 2 | -$2,803,741 | 4 | Director | 19 Mar 2024, 21:48 |
| ADMA | ADMA BIOLOGICS, INC. | 13 Mar 2024 | 3 | -$6,339,417 | 4 | Director | 15 Mar 2024, 21:00 |
| ADMA | ADMA BIOLOGICS, INC. | 26 Feb 2024 | 2 | $0 | 4 | Director | 28 Feb 2024, 21:00 |
| MRKR | Marker Therapeutics, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 21:32 |
| ADMA | ADMA BIOLOGICS, INC. | 06 Mar 2023 | 2 | $0 | 4 | Director | 08 Mar 2023, 20:30 |
| MRKR | Marker Therapeutics, Inc. | 24 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 16:09 |
| ADMA | ADMA BIOLOGICS, INC. | 07 Mar 2022 | 2 | $0 | 4 | Director | 09 Mar 2022, 16:59 |
| ZSAN | Zosano Pharma Corp | 10 Jun 2021 | 2 | $0 | 4 | Director | 14 Jun 2021, 20:38 |
| MRKR | Marker Therapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 18:55 |